Table 3.
FVC, FEV1, and FEV1% of study participants in subsequent statistical analyses
| COPDa
|
Controlb
|
|||||||
|---|---|---|---|---|---|---|---|---|
| Number of cases (%) | FVC | FEV1 | FEV1% | Number of cases (%) | FVC | FEV1 | FEV1% | |
| Sex | ||||||||
| Male | 140 (50.5) | 2.23±0.81 | 1.24±0.47 | 0.56±0.09 | 141 (45.9) | 3.62±0.74 | 3.18±0.81 | 0.88±0.02 |
| Female | 137 (49.5) | 2.42±0.66 | 1.52±0.45 | 0.63±0.07 | 166 (54.1) | 3.46±0.69 | 2.84±0.69 | 0.82±0.05 |
| Age | ||||||||
| Nonelderly group | 78 (28.2) | 2.49±0.84 | 1.56±0.46 | 0.63±0.08 | 208 (67.8) | 3.74±0.81 | 3.41±0.85 | 0.91±0.04 |
| Elderly group | 199 (71.8) | 2.23±0.87 | 1.31±0.44 | 0.58±0.09 | 99 (32.2) | 3.55±0.87 | 2.88±0.87 | 0.81±0.03 |
| BMI | ||||||||
| Normal | 158 (57.1) | 2.54±0.79 | 2.01±0.48 | 0.64±0.06 | 202 (65.8) | 3.97±0.72 | 3.53±0.79 | 0.89±0.04 |
| Underweight | 90 (32.5) | 2.15±0.76 | 1.23±0.49 | 0.57±0.08 | 44 (14.3) | 3.26±0.65 | 2.54±0.83 | 0.78±0.05 |
| Overweight | 29 (10.5) | 2.31±0.82 | 1.41±0.47 | 0.61±0.07 | 61 (19.9) | 3.41±0.77 | 2.76±0.77 | 0.81±0.06 |
Notes:
N=277.
N=307. Data are presented as mean ± standard deviation.
Abbreviations: COPD, chronic obstructive pulmonary disease; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; BMI, body mass index.